Insight into the Structural Features of TSPO: Implications for Drug Development
- PMID: 31864680
- PMCID: PMC7021566
- DOI: 10.1016/j.tips.2019.11.005
Insight into the Structural Features of TSPO: Implications for Drug Development
Abstract
The translocator protein (TSPO), an 18-kDa transmembrane protein primarily found in the outer mitochondrial membrane, is evolutionarily conserved and widely distributed across species. In mammals, TSPO has been described as a key member of a multiprotein complex involved in many putative functions and, over the years, several classes of ligand have been developed to modulate these functions. In this review, we consider the currently available atomic structures of mouse and bacterial TSPO and propose a rationale for the development of new ligands for the protein. We provide a review of TSPO monomeric and oligomeric states and their conformational flexibility, together with ligand-binding site and interaction mechanisms. These data are expected to help considerably the development of high-affinity ligands for TSPO-based therapies or diagnostics.
Keywords: X-ray crystallography; nuclear magnetic resonance; positron emission tomography; protein flexibility; protein ligand interactions.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Conflict of interest statement
DISCLAIMER STATEMENT
The authors declare no conflict of interest
Figures


References
-
- Papadopoulos V et al. (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol. Sci 27(8), 402–409. - PubMed
-
- Fan J et al. (2012) Structural and functional evolution of the translocator protein (18kDa) Curr. Mol. Med 12, 36–386. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources